SCHEMBL14097538

SCHEMBL14097538

CSc1ncc(-c2ccc3[nH]c(NC(=O)NC(C)C)nc3c2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 10/20 0.40
▸ TBK1 Q9UHD2 3/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MTOR P42345 1/20 0.36
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36
▸ TUBB8 Q3ZCM7 1/20 0.36
▸ TUBA3E Q6PEY2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097487 0.85 ABL1 (0.57) ABL1
SCHEMBL14097539 0.84 NPC1 (0.56) ABL1TBK1NPC1RAB9ASMN1; SMN2
SCHEMBL14097550 0.80 ABL1 (0.62) ABL1ALDH1A1
SCHEMBL29813404 0.72 SMN1; SMN2 (0.62) SMN1; SMN2KDM4EALDH1A1POLBMAPT
SCHEMBL18249846 0.72 SMN1; SMN2 (0.62) SMN1; SMN2KDM4EALDH1A1POLBMAPT
SCHEMBL14097429 0.72 ABL1 (0.59) ABL1
SCHEMBL14097445 0.71 ABL1 (0.58) ABL1
SCHEMBL14097618 0.71 DYRK1A (0.55) ABL1
SCHEMBL14097444 0.70 ABL1 (0.54) ABL1
SCHEMBL14097622 0.69 ABL1 (0.59) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
Send feedback